For the largecap pharma companies the game has become completely US-cued. So, US will be the driver for Dr Reddys and Lupin, says Anmol Ganjoo.
first published: Nov 10, 2014 12:16 pm
A collection of the most-viewed Moneycontrol videos.

Nifty Holds Key Support; Volatile Trade Likely on Sensex Expiry | Opening Bell Live

Rupee Slide Weighs Heavy As Nifty Tests 25,900| Midcaps See Sharp Cuts| Closing Bell Live

Meesho's Rs 5,421 Cr IPO Kicks Off| Post-IPO Playbook, Profitability Path & More| IPO Watch Live

Can Nifty Hold Above 26,000 Amid Currency Jitters? Meesho IPO Opens | Opening Bell Live
You are already a Moneycontrol Pro user.

